Personalised genetic insights: A revolution in papillary thyroid cancer
Dec 16, 2024•10 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
While the management of papillary thyroid cancer (PTC) is guided by recurrence risk assessment, current methods cannot accurately predict disease recurrence.
Professor Oliver Bathe and his collaborators at the University of Calgary, Canada, have developed a test that includes genetic data linked to recurrence. Together, they identified three molecular PTC subtypes, allowing more accurate risk assessment to guide clinical decision-making and treatment.
Read more in Research Features
Read the original research: doi.org/10.3389/fendo.2023.1220617
For the best experience, listen in Metacast app for iOS or Android